SCHEMBL25152144

SCHEMBL25152144

CC(C)[C@@H](CC(=O)O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.55
GABBR2 O75899 1/20 0.50
GABBR1 Q9UBS5 1/20 0.50
FFAR1 O14842 2/20 0.47
PLA2G1B P04054 1/20 0.47
ATG4B Q9Y4P1 1/20 0.47
CYP2C19 P33261 3/20 0.46
KCNA3 P22001 1/20 0.45
MAPT P10636 1/20 0.45
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
HSD17B10 Q99714 2/20 0.44
CHRM2 P08172 1/20 0.44
ADRA1A P35348 1/20 0.44
RGS12 O14924 1/20 0.44
GLA P06280 1/20 0.44
CYP3A4 P08684 1/20 0.44
PKM P14618 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25152385 1.00 TAAR1 (0.55) TAAR1GABBR2GABBR1FFAR1PLA2G1B
SCHEMBL1234229 1.00 TAAR1 (0.55) TAAR1GABBR2GABBR1FFAR1PLA2G1B
SCHEMBL7169658 0.89 FFAR1 (0.55) FFAR1PLA2G1BATG4BMAPT
SCHEMBL17050186 0.88 TAAR1 (0.55) TAAR1GABBR2GABBR1PLA2G1BATG4B
SCHEMBL12473262 0.87 GABBR2 (0.57) GABBR2GABBR1CYP2C19MAPTCYP2D6
SCHEMBL26724801 0.86 TAAR1 (0.53) TAAR1PLA2G1BATG4BKCNA3MAPT
SCHEMBL6449839 0.86 GABBR2 (0.48) TAAR1GABBR2GABBR1FFAR1CYP2C19
SCHEMBL10247979 0.86 TAAR1 (0.53) TAAR1PLA2G1BATG4BKCNA3MAPT
SCHEMBL6020157 0.84 GABBR2 (0.52) TAAR1GABBR2GABBR1FFAR1CYP2C19
SCHEMBL185647 0.84 TAAR1 (0.57) TAAR1GABBR2GABBR1PLA2G1BATG4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634396-B2 Opioid receptor modulators EPIODYNE, INC. (US) 2023-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11634396-B2 Opioid receptor modulators OPRM1, OPRK1, OPRL1 TAAR1 173/4885GABBR2 343/4885GABBR1 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.